Skip to content

Does the Pre-operative Use of Probiotic Prevent Ileus In Patients with Colorectal Cancer After Surgery ? A Randomized, Double- Blind, Placebo-Controlled Trial.

Does the Pre-operative Use of Probiotic Prevent Ileus In Patients with Colorectal Cancer After Surgery ? A Randomized, Double- Blind, Placebo-Controlled Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000545561
Enrollment
40
Registered
2015-05-28
Start date
2012-06-02
Completion date
2013-06-12
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To study the efficacy of pre-operative use of probiotic in preventing ileus in patients with colorectal cancer after surgery. Null Hypothesis Pre-operative use of probiotic does not improve gut function and motility in patients with colorectal cancer after surgery.

Interventions

STUDY DESIGN Trial samples Product, Dosage & Administration The Probiotics The probiotic which used in this study is Hexbio by B-Corbes. Hexbio is orange-flavoured granules, which prepared in sealed aluminium, foil pouches. Its’safety for consumption was ascertained with an Acute Oral Toxicty Test. The test was carried out by PSB Singapore and dated 06/04/2009. Hexbio contains 6 strains of live bacteria: 1. Lactobacillus acidophilus 2. Lactobacillus casei 3. Lacto

STUDY DESIGN Trial samples Product, Dosage & Administration The Probiotics The probiotic which used in this study is Hexbio by B-Corbes. Hexbio is orange-flavoured granules, which prepared in sealed aluminium, foil pouches. Its’safety for consumption was ascertained with an Acute Oral Toxicty Test. The test was carried out by PSB Singapore and dated 06/04/2009. Hexbio contains 6 strains of live bacteria: 1. Lactobacillus acidophilus 2. Lactobacillus casei 3. Lactobacillus lactis 4. Bifidobacterium bifidum 5. Bifidobacterium longum 6. Bifidobacterium infantis These bacteria in this probiotic are all acid and bile resistant. They are highly compatible and able to adhere to the intestinal wall. The concentration of the bacteria in Hexbio is 30 billion colony-forming units. Both probiotic and placebo were prepared in sealed aluminium foil pouches which labelled as A (Placebo) and B (Probiotics) respectively. b) Differences between Probiotic & Placebo Preparation Probiotic Placebo 1. Orange-flavoured granules Ascorbic acid 2. 30 billion colony forming units Skim milk powder 3. Lactose 4. Sealed in aluminium foil pouches 5. Labelled as ‘A’ 6. Weight : 30g Administration (Dosage & Duration) The probiotic and placebo group administered their respective preparation 2 times per day for consecutive 7 days prior to operation day. 1st Dose : 0800H 2nd Dose : 2000H The preparations were administered by diluting it with a glass (50cc) of room temperature water. Instruction i. Subjects are requested to consume trial samples for seven (7) days prior to date of operation. ii. Patients will be followed up in the ward after surgery. Recruitment i. Subjects will be recruited from University Hospital of Malaya; or ii. Subjects will be recruited from Surgical Clinic , Univeristy Hospital ; or iii. Questionnaire will be administered to screen the fulfilment of the criteria prior to enrollment. iv. Qualified subjects will be provided with information of the study and informed consent to be obtained. Study duration Length of the study was continued until patients consume normal diet or discharge. They were reviewed by dietician team for calorie & requirement intake Diet during the study i. Continue with the usual normal diets. ii. Consume given trial samples (Probiotic or Placebo) 2 times a day, either before or after meal. iii. Avoid consuming any other probiotics products to prevent confusion

Sponsors

University of Malaya
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

i) The diagnosis of colorectal cancer was confirmed by biopsy and histiological test ii) Patients whose biopsy confirmed colorectal cancer and scheduled to undergo colorectal surgery iii) Age 18 years or above

Exclusion criteria

i. Acute intestinal obstruction ii. Age <18 years iii. Clinically significant immunodeficiency iv. Evidence of infection v. Undergoing emergency operation vi. Gastric outlet obstruction vii. Unable tolerate orally viii. Pregnancy or lactating. ix. Known lactose intolerance x. Unstable psychological conditions or having psychic disorder. xi. Severe medical illness such as end-stage renal failure, liver cirrhosis, advanced connective tissue disease, chronic congestive heart failure. xii. Acute shock. xiii. History of pre-existing arterial disease (recent myocardial infraction, stroke or TIA) and unstable angina pectoris. xiv. Regular ingestion of any probiotics within 1 week prior to recruitment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026